Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16351668 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)
Conditions: Hypercholesterolemia;   Atherosclerotic Disease;   Coronary Disease
Interventions: Drug: MK0653A , ezetimibe (+) simvastatin;   Drug: Comparator: atorvastatin;   Drug: Duration of Treatment: 6 weeks

Indicates status has not been verified in more than two years